Value Collaboration Life Science CompaniesUse Insight Reports Improve Cancer Care Pharma Aptitude Health 2021

The Value of Collaboration: How Life Science Companies Can Use Insight Reports to Improve Cancer Care

Thanks to modern medicine, many cancer patients live longer, healthier lives. These hard-won victories have required a team effort; by working together, life science companies, clinical disease state experts, and community clinicians can dramatically improve cancer care for patients. All 3 entities play a vital role in developing life-saving treatments and ensuring that appropriate patients have access to them.

However, collaboration isn’t always easy. Life science companies often struggle to gather the information they need and to ensure there is alignment between disease-state experts and community-based clinicians. Community oncologists and disease experts are busy with patient care or research and in the wake of the pandemic, physician schedules have become more hectic. Opportunities to meet with life science companies and to collaborate with each other have been severely limited. Life science companies need to be able to access practicing physicians to ensure education and resource needs are properly addressed.

Fortunately, insight reports can help. Insight reports provide detailed information about physician behaviors and treatment patterns in the academic setting as well as in community practice. Life science companies can customize these reports to collect the data they need whether it is on a regional basis or specific to certain patient types. Armed with the right data, life science companies can proceed with confidence. Read on to learn more about how insight reports promote collaboration.

Why Is Collaboration So Essential?
In the fight against cancer, every individual plays an important role. Community oncologists serve as frontline workers; they manage the patient’s illnesses and provide direct care. Disease-state experts participate in clinical trials and help determine factors that influence recommended standards of care. Life science companies focus on drug development and work to ensure there is active communication and collaboration between physicians in both the academic and community setting.

These different factions rely on collaboration to get the job done. Medical experts must share their insights with community oncologists and life science companies. Physicians rely on their deep understanding of the disease state. Information provided by medical experts helps community providers establish more standard approaches across solid tumors and hematologic malignancies.

Life science companies are constantly looking for insights from clinical data and clinician feedback to support the development of new therapies and to maximize the positive impact they can have for patients when approved. Information from disease experts is critical as is the insights provided from community practice providers. Life science companies use this information to help guide their R&D efforts, to build out educational programs, and to make sure patients and their families have the resources and support they need. Successful life science companies keep oncologists closely informed of new treatments and inspire trust in innovative therapy strategies, leading to improved patient outcomes.

Insight reports are a fast, effective way to gather and share information. A high-quality insight report lets your organization stay in touch with medical experts and provides benchmarking data on community treatment standards. Reports also allow your organization to collect and share real-time data with community providers to help them better understand the incorporation of new clinical data in practice and how treatment standards are changing. Many congresses, conventions, and in-person meetings have been moved online or cancelled because of the global pandemic. Insight reports offer a safe and convenient way to bridge the communication gap for life science companies, clinical experts, and community-based clinicians.

How Can Insight Reports Benefit My Organization?
Launching a new product or drug in oncology requires careful coordination and educational support. Payor budgets, established pathways, formulary restrictions, and reimbursement challenges can impact the ability of companies to successfully launch cutting-edge products and deliver new therapies to patients in need.

Psychological barriers can also cause unexpected difficulties. Patients and physicians may be reluctant to try out a recently approved product. If companies fail to provide the educational support needed regarding new treatment approvals, patients and physicians may be slow to trust and utilize novel therapies. They might dismiss a new product as burdensome, limited in unique benefits, or overly expensive.

Before life science companies can undertake a product launch, they must dig into these factors that impact all new products. Companies need to determine what factors drive physicians toward or away from a novel treatment and where gaps exist in the adoption of a new therapy. To avoid costly missteps, companies must also examine barriers that prevent patients from reaping the full benefits of their product.

Insight reports can reveal many key findings for companies launching a new compound. These reports can provide a window into the physician’s mindset, answering vital questions. What treatments do physicians prefer to use? What therapies do they distrust? What are physicians’ primary concerns when choosing a treatment strategy? What research influences their decision, and what recent data might they have overlooked? With the information gathered from insight reports, you can help clinicians answer these questions and more.

How Can I Choose the Right Insight Reports?
Today, many organizations offer packages of curated data for healthcare companies, but not all insight reports are created equal. Some reports provide individual data points, stripped of context. These reports are often minimally useful.

The best reports offer aggregated data, including input from experts. Aptitude Health’s reports provide insight from community physicians and analyses from disease-state experts. These reports deliver a comprehensive view of the cancer care landscape. Aptitude Health reports don’t just take into account the clinical approaches from community oncologists, they include critical commentary and recommendations from disease-state experts on current approaches and considerations. They answer important questions, highlight where community approaches and those in the academic setting are aligned or differ, and draw conclusions based on the data.

With Aptitude Health insight reports, life science companies receive the full picture and gather information from community physicians and medical experts along with recommended next steps to ensure the needs of both are met.

Introducing PIVOT
Aptitude Health’s PIVOT platform uses a unique approach. PIVOT allows providers and experts to exchange oncology information on an ongoing basis. Aptitude Health works with physicians and scientific experts, delivering a well-rounded stream of data. PIVOT reports start with a detailed baseline assessment of 50–150 Axess Network community physicians and their approaches in a specific disease state. Respondents are selected on the basis of their experience in that solid tumor or hematologic malignancy and they provide detailed insights into their current approaches by line of therapy. Their output helps life science companies to understand current clinical approaches, referral patterns, educational gaps, and resource needs. An external Medical Director is assigned on the basis of their clinical expertise in that disease state to lead the project and to provide their insights and recommendations.

The clinical expert presents a detailed review of baseline assessment findings and their recommendations to the life science partner during an interactive presentation and planning session. They review all of the clinical information gathered from community clinicians and offer their insights into current disease management approaches and recommendations for community practices. The clinical expert also highlights key educational gaps that may be impacting current approaches in the community with suggestions on how to best address them. Aptitude Health insight reports and platforms such as PIVOT do more than offer quantitative analyses of patterns, they provide key benchmark information on an ongoing basis to measure changes in community approaches over time.

PIVOT experts understand cutting-edge treatment practices, and they’re aware of the latest research. PIVOT reports offer life science companies a significant advantage in the marketplace and the reports are not just developed for life science partner commercial and clinical teams. Summary reports are provided back to Axess members, highlighting some of the key information gained from the assessment data and the clinical expert’s insights. PIVOT reports ensure that life science partners, disease-state experts, and community-based clinicians have access to data that help improve how they are able to communicate and collaborate together to improve patient outcomes.